A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects
Clinical trial NCT05655221 · UNKNOWN
Trial details
- NCT number
- NCT05655221
- Sponsor
- Tasly Biopharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-30
- Primary completion
- 2023-07-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.